申请人:SCHERING CORPORATION
                            
                            
                                公开号:EP0322633A1
                            
                            
                                公开(公告)日:1989-07-05
                            
                            
Novel mercapto-acylamino acids useful in the treatment of hypertension and combinations of mercapto-acylamino acids and atrial natriuretic factors or angiotensin converting enzyme inhibitors useful for treating hypertension are disclosed.  
                            本研究公开了可用于治疗高血压的新型巯基乙酰
氨基酸,以及可用于治疗高血压的巯基乙酰
氨基酸与心房利
钠因子或
血管紧张素转换酶
抑制剂的组合。